The private and public organizations operating in the UK market are focusing on increasing awareness of gynecological conditions and treatment methods. They are conducting several workshops and events that can guide these procedures. For instance, in November 2021, the British Society for Gynecological Endoscopy (BSGE) conducted diagnostic and operative hysteroscopy workshops in Slough, England. The workshop aimed to develop hysteroscopy skills, and to become familiar with operative hysteroscopic equipment. It is appropriate for trainees in obstetrics and gynecology. Such efforts undertaken by various organizations to improve the knowledge and understanding of these procedures among healthcare professionals and the public are anticipated to drive market growth.
Furthermore, major companies are expanding their product portfolio and focusing on improving the accessibility of these products. For instance, in September 2021, Hologic, Inc. launched its expanded Omni suite to optimize operative and diagnostic hysteroscopy In Europe, including the UK. This suite includes an Omni 30° hysteroscope. In addition, in October 2023, Hologic adopted the HystAR hysteroscopy simulator from Inovus Medical, a supplier of training technologies headquartered in the UK. This simulator offers surgeons a scalable and reproducible environment for hysteroscopy skills training. Thus, the adoption of technologically advanced products from key players is anticipated to boost market growth over the forecast period.
UK Hysteroscopy Procedures Market Report Highlights
- The CPT code 58558 segment dominated the market with a share of more than 33.3% in 2023 owing to the rising number of laparoscopic and hysteroscopic procedures
- The CPT code 58562 segment is projected to grow at the fastest CAGR over the forecast period
- Based on end-uses, the hospitals segment accounted for the largest revenue share of 45.38% in 2023. This dominance can be attributed to the rising investments from government bodies to increase the healthcare infrastructure and build hospitals
- The ambulatory surgical centers (ASCs) segment is expected to register the fastest CAGR from 2024 to 2030
- This growth is due to the several benefits offered by ASCs, such as reduced costs and waiting time
Table of Contents
Companies Mentioned
- Medtronic
- Olympus Corp.
- Stryker Corporation
- B. Braun Melsungen AG
- Johnson & Johnson (Ethicon, Inc)
- Hologic, Inc.
- Delmont Imaging.
- KARL STORZ SE & CO. KG
- Richard Wolf GmbH
- CooperCompanies
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 172 |
Published | May 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 103.55 Million |
Forecasted Market Value ( USD | $ 168.94 Million |
Compound Annual Growth Rate | 7.4% |
Regions Covered | United Kingdom |
No. of Companies Mentioned | 10 |